ArticleBMC infectious diseases2024

HIV-1 pretreatment and acquired antiretroviral drug resistance before tenofovir/ /lamivudine /dolutegravir (TLD) roll-out in Mozambique.

Nália Ismael et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.